HFEA statement on CNR application
24 June 2004
The Human Fertilisation & Embryology Authority (HFEA) is currently considering a licence application from the Newcastle Fertility Centre at Life to make human embryonic stem cells using cell nuclear transfer – a technique also known as therapeutic cloning.
The Research Licence Committee met on the 16th June and decided to request further expert opinion in order to make a decision about whether or not to grant the licence. The committee is now adjourned and will reconvene upon receipt of this information.
If you are a journalist but do not normally receive HFEA press releases and would like to ensure you are notified of the decision, please e-mail the press office with details of your name, publication, telephone number and e-mail address.
Information on the application can be found on our website.
Background information on how the HFEA assesses research applications can be found on our website.
Background information on stem cell research can be found on our website.
Ends
Notes to editors
The HFEA was set up in August 1991 as part of the Human Fertilisation and Embryology Act 1990. The HFEA's principal tasks are to license and monitor clinics that carry out in vitro fertilisation (IVF), donor insemination (DI) and human embryo research. The HFEA also regulates the storage of gametes (eggs and sperm) and embryos.
For further information please contact the HFEA press office.
Page last updated: 12 March 2009